Impact of Acute and Chronic Kidney Disease on Heart Failure Hospitalizations After Acute Myocardial Infarction

医学 肾脏疾病 内科学 心肌梗塞 心力衰竭 急性肾损伤 心脏病学 优势比 血运重建 置信区间 回顾性队列研究 冠状动脉疾病
作者
Srikanth Yandrapalli,John B Christy,Aaqib H Malik,Karan Wats,Prakash Harikrishnan,Wilbert S. Aronow,William H. Frishman
出处
期刊:American Journal of Cardiology [Elsevier]
卷期号:165: 1-11 被引量:1
标识
DOI:10.1016/j.amjcard.2021.10.041
摘要

Very few studies evaluated the impact of acute kidney injury (AKI) and chronic kidney disease (CKD) on heart failure (HF) hospitalization risk following an acute myocardial infarction (AMI). For this retrospective cohort analysis, we identified adult AMI survivors from January to June 2014 from the United States Nationwide Readmissions Database. Outcomes were a 6-month HF, fatal HF, composite of HF during the AMI or a 6-month HF, and a composite of 6-month HF or death during a non-HF-related admission. We analyzed differences in outcomes across categories of patients without renal injury, AKI without CKD, stable CKD, AKI on CKD, and end-stage renal disease (ESRD). Of 237,549 AMI survivors, AKI was present in 13.8%, CKD in 16.5%, ESRD in 3.4%, and AKI on CKD in 7.7%. Patients with renal failure had lower coronary revascularization rates and higher in-hospital HF. A 6-month HF hospitalization occurred in 12,934 patients (5.4%). Compared with patients without renal failure (3.3%), 6-month HF admission rate was higher in patients with AKI on CKD (14.6%; odds ratio [OR] 1.99; 95% confidence interval [CI] 1.81 to 2.19), ESRD (11.2%; OR 1.57; 95% CI 1.36 to 1.81), stable CKD (10.7%; OR 1.72; 95% CI 1.56 to 1.88), and AKI (8.6%; OR 1.52; 95% CI 1.36 to 1.70). Results were generally homogenous in prespecified subgroups and for the other outcomes. In conclusion, 1 in 4 AMI survivors had either acute or chronic renal failure. The presence of any form of renal failure was associated with a substantially increased risk of 6-month HF hospitalizations and associated mortality with the highest risk associated with AKI on CKD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
123发布了新的文献求助10
刚刚
我是老大应助Mister.WangK采纳,获得10
刚刚
1秒前
天天天蓝完成签到,获得积分10
2秒前
白忘幽发布了新的文献求助10
2秒前
3秒前
3秒前
energyharvester完成签到 ,获得积分10
4秒前
5秒前
维嘉发布了新的文献求助10
8秒前
7788完成签到,获得积分10
9秒前
dx发布了新的文献求助10
9秒前
姜峰完成签到,获得积分10
10秒前
10秒前
11秒前
LDA试剂完成签到,获得积分20
11秒前
大意的悟空完成签到 ,获得积分10
12秒前
Owen应助维嘉采纳,获得30
13秒前
飘逸的烧鹅完成签到 ,获得积分10
14秒前
李健的粉丝团团长应助123采纳,获得10
16秒前
16秒前
17秒前
zhangjianzeng完成签到,获得积分10
18秒前
20秒前
Akim应助科研通管家采纳,获得10
23秒前
丘比特应助科研通管家采纳,获得10
23秒前
不安青牛应助科研通管家采纳,获得10
23秒前
Hello应助科研通管家采纳,获得10
23秒前
23秒前
一二应助科研通管家采纳,获得10
23秒前
23秒前
cctv18应助科研通管家采纳,获得10
23秒前
温酒随行发布了新的文献求助10
24秒前
25秒前
nmk完成签到,获得积分10
25秒前
CharlotteBlue应助cctv_x采纳,获得30
27秒前
hsj123123完成签到,获得积分10
27秒前
云瑾应助奋斗的松思采纳,获得10
27秒前
29秒前
快乐的小康完成签到,获得积分20
29秒前
高分求助中
Manual of Clinical Microbiology, 4 Volume Set (ASM Books) 13th Edition 1000
Counseling With Immigrants, Refugees, and Their Families From Social Justice Perspectives pages 800
マンネンタケ科植物由来メロテルペノイド類の網羅的全合成/Collective Synthesis of Meroterpenoids Derived from Ganoderma Family 500
Electrochemistry 500
Broflanilide prolongs the development of fall armyworm Spodoptera frugiperda by regulating biosynthesis of juvenile hormone 400
Statistical Procedures for the Medical Device Industry 400
藍からはじまる蛍光性トリプタンスリン研究 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2373023
求助须知:如何正确求助?哪些是违规求助? 2080737
关于积分的说明 5212464
捐赠科研通 1808170
什么是DOI,文献DOI怎么找? 902522
版权声明 558275
科研通“疑难数据库(出版商)”最低求助积分说明 481829